Sulfiredoxin–Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling

Qiou Wei(University of South Dakota), Nancy H. Colburn(Gene Therapy Laboratory), Zhen Xiao(Anatech), Hong Jiang, Matthew R. Young(NYU Langone Health), Alyson R. Baker(National Cancer Institute), Timothy D. Veenstra(Leidos (United States))
Proceedings of the National Academy of Sciences
April 12, 2011
Cited by 113


Related Papers